However, as EGFR expression was reduced by EGFR shRNA, Lycorine’s inhibition on GBM growth also declined dramatically (Fig. 7d, green curve, compared with the orange curve of shControl group treated with 20 mg/kg/day of Lycorine, ** P < 0.01). This evidence concerns the gene EGFR and glioblastoma.